BEAG
NASDAQ · N/A
Bold Eagle Acquisition Cor-A
$10.59
+0.00 (+0.00%)
Open$10.58
Previous Close$10.59
Day High$10.60
Day Low$10.58
52W High$11.11
52W Low$10.18
Volume—
Avg Volume25.3K
Market Cap219.04M
P/E Ratio27.57
EPS$0.25
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 142.01M | 141.93M | 117.76M |
| Net Income | 28.02M | 21.94M | 19.87M |
| Profit Margin | 19.7% | 15.5% | 16.9% |
| EBITDA | 38.75M | 41.75M | 38.09M |
| Free Cash Flow | 17.45M | 15.30M | 15.02M |
| Rev Growth | +17.2% | +6.5% | +22.4% |
| Debt/Equity | 0.73 | 0.64 | 0.80 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $2.03 | +6.28% | — | 1.03B |
| PICS | Pics Nv | $6.87 | -3.10% | 3.7 | 920.07M |
| DMII | Drugs Made In America Acquis | $10.22 | -0.05% | 49.9 | 649.74M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| CEPF | Cantor Equity Partners-Cl A | $10.32 | -0.10% | 41.5 | 589.79M |
| BCSS | Bain Capital Gss Inv- A | $10.22 | +0.05% | 48.7 | 597.72M |